1,561 results on '"Lordick, Florian"'
Search Results
2. Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
3. Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer
4. Herausforderungen in der Primärtherapie älterer Patienten mit Kopf-Hals-Tumoren
5. German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
6. National guidelines for gastric cancer: redundant or needed?
7. Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract
8. Physical exercise as a treatment for persisting symptoms post-COVID infection: review of ongoing studies and prospective randomized controlled training study
9. The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinoma
10. Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer
11. HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer
12. Lungenmetastasen – Onkologische Bedeutung und Therapie
13. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
14. Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors
15. Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer
16. European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)
17. Standardizing eligibility and patient selection for Pressurized Intraperitoneal Aerosol Chemotherapy: A Delphi consensus statement
18. Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers
19. Effect of home-based online training and activity feedback on oxygen uptake in patients after surgical cancer therapy: a randomized controlled trial
20. Physical and psychosocial factors associated with sexual satisfaction in long-term cancer survivors 5 and 10 years after diagnosis
21. Study protocol: the OptiScreen-Study: optimized psycho-oncological care—from screening to intervention
22. Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study
23. Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer
24. Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
25. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
26. Comparative bioinformatic analysis of KRAS, STK11 and KEAP1 (co-)mutations in non-small cell lung cancer with a special focus on KRAS G12C
27. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
28. Was ist gesichert in der Therapie des Kolonkarzinoms
29. Kapazität der onkologischen Versorgung in deutschen onkologischen Spitzenzentren während der ersten 2 Jahre der COVID-19-Pandemie
30. Metastasen
31. Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
32. Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe
33. Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study
34. Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer
35. Predictors for thromboembolism in patients with cholangiocarcinoma
36. Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer
37. Improved survival of locoregional-advanced larynx and hypopharynx cancer patients treated according to the DeLOS-II protocol
38. Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).
39. Digital Therapeutic (Mika) Targeting Distress in Patients With Cancer: Results From a Nationwide Waitlist Randomized Controlled Trial
40. Immuntherapie bei gastrointestinalen Tumoren
41. Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort study
42. Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation
43. Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies—the role of HAS2, SHB and HBEGF
44. The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally
45. Cancer prevention in females with and without obesity: Does perceived and internalised weight bias determine cancer prevention behaviour?
46. Importance of Systemic Chemotherapy in Advanced Peritoneal Metastasis
47. Training kommunikativer Fertigkeiten in der Onkologie: Implementierung und Pilotierung des interprofessionellen COMSKIL-Gesprächsführungskurses am Universitären Krebszentrum Leipzig (UCCL)
48. Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials
49. Plattenepithelkarzinome des Kopf- und Halsbereichs: Bewährte und innovative Strategien verbessern Outcome
50. Wirksamere Therapien bei Magenkrebs erreichen die Praxis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.